Related Articles |
[Clinical Efficacy of Paclitaxel plus Bevacizumab Combination Therapy for Bone Marrow Carcinomatosis Arising from Breast Cancer – A Case Report].
Gan To Kagaku Ryoho. 2017 Nov;44(12):1391-1392
Authors: Nakayama I
Summary
We report a case of a 42-year-old girl with bone marrow carcinomatosis in the middle of metastatic breast most cancers who responded properly to paclitaxel plus bevacizumab(PTX plus Bev)mixture remedy. 4 years after preliminary breast conserving surgical procedure, she was admitted to our hospital with again ache and normal malaise and was recognized as a number of bone metastases with bone marrow carcinomatosis originating from earlier breast most cancers(ER+/HER2-). Whereas administering denosumab, we initiated systemic chemotherapy with PTX plus Bev. There was no signal of development at 1 12 months after starting the therapy. Subsequently, we conclude that PTX plus Bev mixture remedy could possibly be efficient and sustainable therapy for bone marrow carcinomatosis arising from metastatic breast most cancers.
PMID: 29394644 [PubMed – in process]